"Within five years a slew of new diagnostic tests will allow us to detect disease early, when it can be treated, rather than when it is too late, " says Patrick Plewman, Diadexus' chief executive.
Another need is better diagnostic tests and sensors that can detect and identify biological agents or chemical agents early in a terror attack before there are many casualties.